potential for RNA-binding small molecules as both therapeutic agents and cellular probes.
Unfortunately, the multiple secondary structures that RNA can adopt have caused difficulty in
the development of a general paradigm for RNA− small molecule binding. In particular, the
standard RNA-binding compounds such as aminoglycosides do not generally bind RNA
hairpin loops, a widespread and vitally important secondary structural motif. In this …